The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Borrower

4•••• I••

Pharmaceuticals, Biotechnology & Life Sciencesgroup grade Con a schedule nowsponsor unattributed
Principal held
at least $19.9M
sum of BDC pieces, a lower bound
Fair value
$28.6M
107c on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
1 equity pieces beside them
Next maturity
Dec 31, 2027
$19.9M inside 24 months
On the tape since
Jun 30, 2026
latest Jun 30, 2026
Events
1
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
FacilityHeldOn costPricingMaturityBDCs
first lien term loan first lienat least $19.9M107cSOFR+925 bpDec 31, 20271
Equity pieces beside the debt: warrants ($4.2M fair value, 1 BDC)
Lenders
every BDC piece at the latest quarter end
BDCInstrumentPrincipalFair valueRate
R••••• G••••• F•••••• C••••warrants equity
W••••••• & O•••• C••••••••• R••••• Investment T••• W•••••• S••••• D P••••••••• S•••• I••••
n/a$4.2M
106c
R••••• G••••• F•••••• C••••term loan first lien
Investment T••• S••••• S•••••• I••••••• R••• S•••+9.25%, 12.75% floor, 34.43% ETP I••••••
$19.9M$24.3M
107c
SOFR+925 bp
Through time
the borrower's pieces summed across BDCs, every quarter end
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Jun 30, 20261$19.9M$24.3M107c0
What changed
Every change including routine ones
Identity
Group key
4WEBderivedthe codename stem after legal suffixes and deal words
Spellings
1 across 1 BDCderived
Industry
Pharmaceuticals, Biotechnology & Life Sciencesreportedas one filer wrote it